“…Immense AEDs, hailing from different groups, are commonly used to control seizures, like phenytoin, carbamazepine, valproic acid, topiramate, gabapentin, felbamate, levetiracetam, etc. 6 A significant percentage of epileptic patients have acceptable AED enhancements, but they represent drawbacks such as insufficient seizure regulation, unpredictability of affect and failure, low effectiveness, inadequate knowledge on drug receptors, etc. and the most important downside is the possibility of drug resistance.…”